Home » Topics » BioWorld Science

BioWorld Science
RSS

Affimed outlines plans for clinical development and registrational plans for AFM-13

Dec. 10, 2018

Avacta enters development alliance with LG Chem Life Sciences

Dec. 10, 2018

Phase I/II trial data of VAL-201 show dose-dependent response in PSA reduction

Dec. 10, 2018

C4X Discovery Holdings and e-therapeutics collaboration meets success

Dec. 10, 2018

Taizhou Huayuan Medicinal Tech describes deuterated anxiolytic compounds

Dec. 10, 2018

Idorsia Pharmaceuticals patents prostanoid EP2 and/or EP4 receptor antagonists

Dec. 10, 2018

New P2X4 receptor antagonists synthesized at Bayer

Dec. 10, 2018

Sigma1R ligands described by Integrative Research Laboratories Sweden

Dec. 10, 2018

Arctic Pharma discovers lactate dehydrogenase A inhibitors

Dec. 10, 2018

Bristol-Myers Squibb and Vedanta collaborate to study Opdivo with VE-800 in advanced cancers

Dec. 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...